TrialDrug design, development and therapy2024

Fenofibrate as an Adjunct Therapy for Ulcerative Colitis: Targeting Inflammation via SIRT1, NLRP3, and AMPK Pathways: A Randomized Controlled Pilot Study.

Sumaiah J Alarfaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.